Vaccines Day: Moderna Reveals Breakthrough Data on 3 New Shots, Including Norovirus, Epstein-Barr, and Shingles – What You Need to Know Now!
Boston, MA – Moderna recently announced positive data from clinical trials on three new experimental vaccines, showcasing the company’s efforts to expand beyond its well-known Covid vaccine. These vaccines are now moving towards final stages of study, marking a significant step towards diversifying Moderna’s product portfolio. The update comes at a crucial time for the company, given the decline in demand for Covid shots worldwide. With its Covid vaccine being the only product commercially available, …